Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: Subgroup analyses by region, including Japan, from the global randomized Phase III trial
Tatsuya Ioka, Takuji Okusaka, Shinichi Ohkawa, Narikazu Boku, Akira Sawaki, Yosuke Fujii, Yoichi Kamei, Satori Takahashi, Katsushi Namazu, Yoshiko Umeyama, Paul Bycott, Junji Furuse
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
35
被引用数
(Scopus)